491 related articles for article (PubMed ID: 29505580)
1. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
[TBL] [Abstract][Full Text] [Related]
3. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
4. Elimination of Onchocercia volvulus transmission in the Santa Rosa focus of Guatemala.
Lindblade KA; Arana B; Zea-Flores G; Rizzo N; Porter CH; Dominguez A; Cruz-Ortiz N; Unnasch TR; Punkosdy GA; Richards J; Sauerbrey M; Castro J; Catú E; Oliva O; Richards FO
Am J Trop Med Hyg; 2007 Aug; 77(2):334-41. PubMed ID: 17690408
[TBL] [Abstract][Full Text] [Related]
5. Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test.
Dolo H; Coulibaly YI; Dembele B; Guindo B; Coulibaly SY; Dicko I; Doumbia SS; Dembele M; Traore MO; Goita S; Dolo M; Soumaoro L; Coulibaly ME; Diallo AA; Diarra D; Zhang Y; Colebunders R; Nutman TB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007064. PubMed ID: 30699120
[TBL] [Abstract][Full Text] [Related]
6. Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
Lovato R; Guevara A; Guderian R; Proaño R; Unnasch T; Criollo H; Hassan HK; Mackenzie CD
PLoS Negl Trop Dis; 2014 May; 8(5):e2821. PubMed ID: 24853587
[TBL] [Abstract][Full Text] [Related]
7. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
Eisenbarth A; Achukwi MD; Renz A
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004392. PubMed ID: 26926855
[TBL] [Abstract][Full Text] [Related]
8. Interruption of Onchocerca volvulus transmission in Northern Venezuela.
Convit J; Schuler H; Borges R; Olivero V; Domínguez-Vázquez A; Frontado H; Grillet ME
Parasit Vectors; 2013 Oct; 6(1):289. PubMed ID: 24499653
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
Wilson NO; Badara Ly A; Cama VA; Cantey PT; Cohn D; Diawara L; Direny A; Fall M; Feeser KR; Fox LM; Kabore A; Seck AF; Sy N; Ndiaye D; Dubray C
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005198. PubMed ID: 27926918
[TBL] [Abstract][Full Text] [Related]
10. Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
Djune-Yemeli L; Domché A; Nana-Djeunga HC; Donfo-Azafack C; Lenou-Nanga CG; Masumbe-Netongo P; Kamgno J
PLoS Negl Trop Dis; 2022 May; 16(5):e0010380. PubMed ID: 35499993
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.
Mukendi D; Tepage F; Akonda I; Siewe JNF; Rotsaert A; Ndibmun CN; Laudisoit A; Couvreur S; Kabutako B; Menon S; Hotterbeekx A; Colebunders R
Int J Infect Dis; 2019 Feb; 79():187-194. PubMed ID: 30711145
[TBL] [Abstract][Full Text] [Related]
12. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
13. Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala.
Gonzalez RJ; Cruz-Ortiz N; Rizzo N; Richards J; Zea-Flores G; Domínguez A; Sauerbrey M; Catú E; Oliva O; Richards FO; Lindblade KA
PLoS Negl Trop Dis; 2009; 3(3):e404. PubMed ID: 19333366
[TBL] [Abstract][Full Text] [Related]
14. Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.
Lont YL; Coffeng LE; de Vlas SJ; Golden A; de Los Santos T; Domingo GJ; Stolk WA
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005314. PubMed ID: 28114304
[TBL] [Abstract][Full Text] [Related]
15. Interruption of onchocerciasis transmission in Bioko Island: Accelerating the movement from control to elimination in Equatorial Guinea.
Herrador Z; Garcia B; Ncogo P; Perteguer MJ; Rubio JM; Rivas E; Cimas M; Ordoñez G; de Pablos S; Hernández-González A; Nguema R; Moya L; Romay-Barja M; Garate T; Barbre K; Benito A
PLoS Negl Trop Dis; 2018 May; 12(5):e0006471. PubMed ID: 29723238
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
Senyonjo L; Oye J; Bakajika D; Biholong B; Tekle A; Boakye D; Schmidt E; Elhassan E
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004905. PubMed ID: 27529622
[TBL] [Abstract][Full Text] [Related]
17. The blackfly vectors and transmission of Onchocerca volvulus in Mahenge, south eastern Tanzania.
Hendy A; Krüger A; Pfarr K; De Witte J; Kibweja A; Mwingira U; Dujardin JC; Post R; Colebunders R; O'Neill S; Kalinga A
Acta Trop; 2018 May; 181():50-59. PubMed ID: 29410302
[TBL] [Abstract][Full Text] [Related]
18. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.
Golden A; Faulx D; Kalnoky M; Stevens E; Yokobe L; Peck R; Karabou P; Banla M; Rao R; Adade K; Gantin RG; Komlan K; Soboslay PT; de Los Santos T; Domingo GJ
Parasit Vectors; 2016 Jun; 9(1):338. PubMed ID: 27296630
[TBL] [Abstract][Full Text] [Related]
19. Assessment and monitoring of onchocerciasis in Latin America.
Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
[TBL] [Abstract][Full Text] [Related]
20. Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
Evans DS; Alphonsus K; Umaru J; Eigege A; Miri E; Mafuyai H; Gonzales-Peralta C; Adamani W; Pede E; Umbugadu C; Saka Y; Okoeguale B; Richards FO
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3113. PubMed ID: 25233351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
